rss

About Annals of the Rheumatic Diseases

Aims and Scope

Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer reviewed proceedings of international meetings are featured. Educational papers include state of the art reviews, "how to" articles and educational cases that focus on problems faced in clinical practice. The journal was first published in 1939 and has an authorative global Editorial Board and a growing international readership.

Ownership

ARD is co-owned by the European League Against Rheumatism (EULAR) and BMJ.

Journal Statistics

Acceptance rate 22% for original research submitted in 2013
Time from submission to first decision


24 days for reviewed original articles

Time from acceptance to publication

17 days (online)
220 days (print)

Frequency Monthly
Impact Factor 9.111
Indexed by Science Citation Index, Index Medicus (Medline), Excerpta Medica (Embase), BIOSIS Previews, Sociedad Iberoamericana de Informacion Cientifica (SIIC)
Launch date 1939
ISSN of ARD 0003-4967
ISSN of ARD Online 1468-2060

Contact Information

For all contact information please refer to the Contact Us page.

For Authors

Please refer to the Instructions for Authors

Rights and Permissions

Copyright and Permissions Guidelines

Affiliations

 

COPEBMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.

AllTrials logoBMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.


 

Free sample This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ARD.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.